Nicholas Borys

Nicholas Borys currently works at MedTrace Pharma AS, as Chief Executive Officer & Chief Medical Officer from 2024.
Dr. Borys also formerly worked at Jazz Pharmaceuticals (EUSA Pharma USA), Inc., as Principal, Imunon, Inc., as Chief Medical Officer & Executive Vice President from 2017 to 2023, Anthra Pharmaceuticals, Inc., as Principal, Molecular Insight Pharmaceuticals, Inc., as Chief Medical Officer from 2004 to 2007, Hoffmann-La Roche, Inc., as Principal, and Taiho Pharmaceutical Co., Ltd., as Chief Medical Officer & Vice President in 2004.
Dr. Borys received his undergraduate degree in 1981 from Rutgers State University of New Jersey and doctorate degree from American University of The Caribbean School of Medicine.